Zydus Lifesciences Limited — Board Meeting, 11-08-2026: Outcome of Board Meeting
11-08-2026 | 01:24 pm
11-08-2026 | 01:24 pm
Zydus Lifesciences' board approved the financial results for the quarter ended June 30, 2026. Consolidated revenue reached ₹8,017 Cr, with net profit standing at ₹939.8 Cr.
No comments yet. Be the first to comment!
